Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Topical Pain Relief Market size was valued at USD 11.08 billion in 2024 and is expected to reach USD 21.68 billion by 2037, expanding at around 5.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of topical pain relief is assessed at USD 11.58 billion.
Topical Pain Relief Sector: Growth Drivers and Challenges
Growth Indicators
As per the statistics of the American College of Rheumatology, osteoarthritis is the most common form of arthritis and it affects around 302 million people worldwide, every year.
Growing incidences of arthritis, particularly osteoarthritis across the world is a primary factor, which is anticipated to propel the market growth over the forecast period. Osteoarthritis is also a leading cause of disability among older adults, wherein the most affected appendicular joints are knees, hips, and joints. According to the Arthritis Foundation, arthritis in tandem with back pain is a leading cause of work disability in the US. It is also the most common cause, which requires rehabilitation and thus has the greatest impact on the healthcare system in the country. On the other hand, rising adoption of analgesics for instant pain relief is another major factor anticipated to drive the market growth over the forthcoming years. Topical pain relievers are available in multiple forms such as gels, ointments, creams, and sprays, which not only have lesser systemic side effects as compared to a similar oral dosage but can also be compounded and individualized in the right concentration as per the specific needs of the consumer. Additionally, the growing popularity of topical as well as transdermal creams and patches among the sportspersons, on account of its numerous advantages has directly impacted its increased adoption. Sports-related soft tissue injuries, such as strains, sprains, and contusions are extremely common. As per the statistics of Sandford Children’s Health, approximately 30 million children and teens in the US participate in some form of sports, wherein more than 3.5 million children experience some sort of physical injury. Such factors are anticipated to drive the growth of the global topical pain relief market.
Challenges
Limited availability of topical pain relievers for neonates and pediatrics, as the use of topical anesthetics and analgesics in children generally requires a proper prescription, along with the concern for severe allergic reactions on the back of excessive and continuous use of topical gels and creams are some of the factors anticipated to impact negatively towards the growth of the global topical pain relief market.
Topical Pain Relief Market: Key Insights
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
5.3% |
|
Base Year Market Size (2023) |
USD 10.52 billion |
|
Forecast Year Market Size (2036) |
USD 20.59 billion |
|
Regional Scope |
|
Topical Pain Relief Segmentation
The global topical pain relief market has been segmented on the basis of therapeutic class into opioids and non-opioids. The non-opioids segment is further sub-divided into non-steroidal anti-inflammatory drugs, lidocaine and others. The non-steroidal anti-inflammatory drugs segment with 54.31% share in the year 2037, occupies the largest market of topical pain relievers across the globe. Additionally, the non-steroidal anti-inflammatory drugs segment is anticipated to cross USD 6747 million by the end of 2028 by registering a CAGR of 4.21% over the forecast period. Further, the lidocaine segment is estimated to grow with the highest CAGR of 4.49% over the forecast period.
Our in-depth analysis of the global market includes the following segments:
|
Therapeutic Class |
|
|
Type |
|
|
Formulation |
|
|
Distribution Channel |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportTopical Pain Relief Industry - Regional Synopsis
North America industry is set to account for largest revenue share of 78% by 2037, North America industry is set to hold largest revenue share of 78% by 2037, Growing incidences of arthritis in the region, increasing geriatric population, rising incidences of sport-related injuries, rising consumer awareness for topical pain relief products and growing utilization of topical pain relievers are some of the factors driving the growth of the market in North America. Additionally, the North America topical pain relief market, which held a share of 39.68% in the year 2019, is expected to expand by observing the growth rate of 1.29x over the forecast period, which in turn is estimated to have a positive effect on the demand for topical pain relievers in the long run.
Further, U.K., Germany, Italy and France are some of the prominent countries that are driving the growth of the Europe topical pain relief market, where U.K. accounted for the largest market share of 20.87% in the year 2019. Continuous advancements pertaining to the increased adoption of transdermal patches for chronic disorders, coupled with the increasing R&D investments by few major players are among the major factors expected to propel the growth of the topical pain relief market in Europe.
Companies Dominating the Topical Pain Relief Landscape
- Reckitt Benckiser Group plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Teikoku Pharma USA, Inc.
- Topical BioMedics, Inc.
- Sun Pharmaceutical Industries Ltd.
- AdvaCare Pharma®,
- Sanofi,
- Johnson & Johnson Services, Inc.,
- Novartis AG, Pfizer Inc.
- GlaxoSmithKline plc.
In the News
Author Credits: Radhika Pawar
- Report ID: 2473
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT
